Results 191 to 200 of about 341,736 (266)

Pregnancy‐related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas   +16 more
wiley   +1 more source

Metabolic Endotoxemia Amplifies Estrogen Signaling Through Stromal Crosstalk in Obesity-Associated Breast Cancer. [PDF]

open access: yesInt J Mol Sci
Drai E   +9 more
europepmc   +1 more source

Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study is to evaluate the effects of multiple doses of esomeprazole, a strong proton pump inhibitor and acid‐reducing agent, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader.
Lana Tran   +7 more
wiley   +1 more source

Association Between Hormone Replacement Therapy and Incidence of Tendon Injuries and Surgical Repair in Perimenopausal Women: A Propensity Score-Matched National Cohort Study. [PDF]

open access: yesOrthop J Sports Med
Bcharah G   +8 more
europepmc   +1 more source

Influence of Menopause Onset on the Progression of Lumbar Degenerative Disease: A Clinical Correlation Study. [PDF]

open access: yesJ Orthop Case Rep
Ganguly S   +5 more
europepmc   +1 more source

Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha. [PDF]

open access: yesMicroPubl Biol
Elzaghir R   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy